Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Monash IVF Group Ltd ( (AU:MVF) ) has issued an announcement.
Monash IVF Group has disclosed a change in director Catherine Ann Aston’s shareholding following the lodgement of an Appendix 3Y notice. Aston has disposed of 75,000 indirectly held ordinary shares in the company, leaving her with a direct holding of 2,000 shares, after her superannuation fund Telstra Super closed its ‘Direct Access’ investment platform and required compulsory disposal of all securities held through that facility, indicating the change is driven by administrative platform changes rather than a discretionary decision about the company’s prospects.
The most recent analyst rating on (AU:MVF) stock is a Hold with a A$0.94 price target. To see the full list of analyst forecasts on Monash IVF Group Ltd stock, see the AU:MVF Stock Forecast page.
More about Monash IVF Group Ltd
Monash IVF Group Limited is an Australia-listed healthcare company specialising in assisted reproductive services, including in vitro fertilisation (IVF) and related fertility treatments. The group operates clinics and associated services focused on helping patients with fertility and reproductive health needs across its key markets.
Average Trading Volume: 2,496,352
Technical Sentiment Signal: Sell
Current Market Cap: A$286.4M
See more insights into MVF stock on TipRanks’ Stock Analysis page.